| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 115.930 | 104.581 | 111.228 | 113.821 | 128.567 | 155.412 | 181.982 | 188.105 | 240.088 | 237.668 |
| Total Income - EUR | 128.386 | 116.611 | 122.692 | 125.047 | 139.555 | 168.936 | 181.982 | 188.105 | 242.253 | 246.765 |
| Total Expenses - EUR | 119.813 | 126.933 | 107.685 | 111.402 | 129.088 | 141.663 | 179.167 | 188.895 | 238.249 | 239.032 |
| Gross Profit/Loss - EUR | 8.573 | -10.322 | 15.007 | 13.645 | 10.467 | 27.273 | 2.816 | -790 | 4.004 | 7.733 |
| Net Profit/Loss - EUR | 7.367 | -10.322 | 11.363 | 12.506 | 9.181 | 25.752 | 996 | -2.671 | 1.583 | 330 |
| Employees | 7 | 7 | 8 | 8 | 9 | 9 | 8 | 7 | 7 | 6 |
Check the financial reports for the company - Xando Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 83.572 | 74.008 | 59.631 | 50.407 | 36.189 | 22.513 | 9.328 | 43.748 | 33.088 | 59.149 |
| Current Assets | 12.700 | 7.884 | 13.440 | 18.427 | 19.135 | 27.431 | 18.332 | 3.227 | 12.250 | 11.376 |
| Inventories | 2.049 | 3.317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.642 | 1.780 | 1.876 | 2.534 | 2.946 | 1.786 | 1.998 | 2.422 | 2.571 | 4.561 |
| Cash | 9.008 | 2.787 | 11.564 | 15.892 | 16.189 | 25.645 | 16.334 | 805 | 9.679 | 6.815 |
| Shareholders Funds | 1.663 | -10.268 | 1.269 | 13.752 | 22.667 | 27.761 | 19.629 | 3.999 | 5.569 | 5.869 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 49.052 | 103.063 | 47.298 | 41.034 | 28.971 | 22.871 | 8.319 | 43.634 | 40.520 | 65.085 |
| Income in Advance | 58.517 | 45.890 | 33.699 | 21.876 | 10.464 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Xando Med S.r.l.